Ian 2012
Iam Solomon,
Co-founder & CTO of OmnySense
Jack Mark white background 2.2
Jack Mark,
Director -US Division
Daniel Valens
Daniel Adler,
CEO & Co-founder of BioT

The Covid-19 pandemic has accelerated the need for virtual care, especially remote patient monitoring. An upcoming webinar will highlight how medical device manufacturer OmnySense is taking on the challenge of remote monitoring for chronic conditions.
The conversation will explore how OmnySense is using BioT’s connected care platform to
support home care and remote patient monitoring. The combined system helps patients stay connected to caregivers by enhancing telemedicine calls, spotting warning signs earlier,
and triggering timely interventions.


  • How IoMT platforms enable healthcare providers, caregivers, and medtech companies to provide a personalized and full continuum of care, even at home, with the purpose of extending and improving the quality of life
  • How, with the help of a connected care platform, caregivers and medical device companies can optimize their resources and workflows, gain meaningful insights from direct engagement with patients, and introduce new business models
  • How OmnySense and BioT are introducing a regulated home care medical monitoring platform to enable caregivers and healthcare providers to treat their patients remotely

OmnySense is developing a multi-parameter medical device for home check-ups, seamlessly integrated into OmnySense’s cloud-based telehealth system for remote health tracking, powered by BioT.

BioT is an easy-to-integrate cloud-based platform designed to instantly connect between medical devices, patients, caregivers and data, to ensure a seamless continuum of care.


Ian Solomon, Co-founder & CTO, OmnySense
Serial entrepreneur in the medical device and drug delivery fields. Prior to co-founding OmnySense, he co-founded TimeStamp, which developed a connected solution for monitoring drug adherence, especially for inhalers. Previously, he was a co-founder of electronic patch-pump company SteadyMed, which was sold to United Therapeutics for $216 million.

Before his involvement in the medical world, Ian worked for over 20 years in information systems and communications in a range of technical and marketing positions. 
Ian holds a BSc. in Physics from Sussex University, UK.

Jack Mark, Director - US Division, BioT

Jack is a serial entrepreneur specializing in the MedTech Sector.  He founded Mobile Heartbeat™  in 2009, creating the gold standard Collaborative Mobile Application for acute care facilities. The company was acquired in 2016 by HCA – the largest IDN in the US. Subsequently, Jack is active as a Mass Challenge mentor and judge while also participating in several Angel investment groups and helping startups with sales strategies.

Jack recently joined BioT as Director – US Division.

Daniel Adler, CEO, Co-founder, BioT

Daniel is the CEO & Co-Founder of BioT and has extensive experience in IT, internet and telecom. Previously, he was part of Valens’ management, a leading semiconductor company in the area of high-speed connectivity, where he led the Automotive Business Unit and managed all automotive activities and partnerships with key OEMs and Tier-1/2s worldwide. Prior to Valens, Daniel was VP Sales and Business Development at 3i-MIND, where he built the sales and marketing processes from scratch. He also served as Director of Business Development and Strategic Accounts at NICE Systems, in charge of worldwide key accounts.  Daniel holds a B.Sc. in Computers from the Technion Israel Institute of Technology.


Watch On-Demand